Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone pulse therapy for COVID-19 patients with acute respiratory distress syndrome
IRCT20200406046963N1Phase 3Completed
- Sponsor
- Aja University of Medical Sciences
- Start
- Mar 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of methylprednisolone in coronavirus disease 2019 (COVID-19) and acute respiratory distress syndrome (ARDS), sponsored by Aja University of Medical Sciences. Started Mar 2020; status: completed.
02
Drugs
methylprednisolone
03
Conditions
coronavirus disease 2019 (COVID-19)acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on IRCT20200406046963N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200406046963N1.